U.S. officials worried about Chinese control of American drug supply

13 September 2019 - "Basically we've outsourced our entire industry to China," retired Brig. Gen. John Adams told NBC News. "That ...

Read more →

China’s grip on pharmaceutical drugs is a national security issue

10 September 2019 - If you take a pill every day to treat high blood pressure or high cholesterol, you ...

Read more →

Tagrisso approved in China as a first-line treatment for EGFR-mutated non-small cell lung cancer

4 September 2019 - In the Phase III FLAURA trial, Tagrisso significantly increased the time patients lived without disease progression ...

Read more →

China expands drug bulk-buy program, puts pressure on pharma firms

2 September 2019 - China has expanded a pilot drug bulk-buying program to almost the entire country in an attempt ...

Read more →

China eases rules on cheap drug imports to fight chronic diseases

27 August 2019 - China said it would reduce the penalties for the sale and import of unapproved drugs, effectively ...

Read more →

China loosens curbs on small, unapproved drug imports

26 August 2019 - China said on Monday it was relaxing drug laws to give greater leniency to people who ...

Read more →

China revises law to ensure drug safety

26 August 2019 - China's top legislature on Monday voted to adopt the revision to the drug administration law as ...

Read more →

China vows to maintain stable drug prices

22 August 2019 - Chinese authorities vowed to take actions to make sure the drug prices are set reasonably by ...

Read more →

Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease

22 August 2019 - China becomes the first country to approve roxadustat for all chronic kidney disease patients with anaemia ...

Read more →

China adds 148 drugs to key insurance list

20 August 2019 - China on Tuesday added 148 drugs to its list of medicines covered by basic medical insurance ...

Read more →

China National Medical Products Administration approves Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) for treatment of HIV-1 infection

9 August 2019 - Biktarvy demonstrated high efficacy and a high barrier to resistance in clinical trials through 48 weeks. ...

Read more →

China increases drug price control measures

5 August 2019 - From 1996, the Chinese government has adopted more than 30 price control strategies in an attempt to ...

Read more →

U.S. dependence on China for medicine is a major problem

21 July 2019 - As tensions with China have escalated over the past year, Washington, D.C., is finally waking up ...

Read more →

UCB announces approval of Cimzia in China

22 July 2019 - After receiving priority review in 2018, Cimzia (certolizumab pegol) is now approved in China for the treatment ...

Read more →

Novartis key multiple sclerosis product Gilenya approved in China

19 July 2019 - Chinese National Medical Products Administration (NMPA) approved Gilenya for relapsing forms of multiple sclerosis for adults and ...

Read more →